| JP2766473B2 (en)* | 1987-01-08 | 1998-06-18 | 旭化成工業株式会社 | Peptide promoting the activation of protein C by thrombin |
| US4912207A (en)* | 1987-05-06 | 1990-03-27 | Washington University | DNA clone of human thrombomodulin and portions thereof |
| WO1990010081A1 (en)* | 1989-02-17 | 1990-09-07 | Codon | Soluble analogs of thrombomodulin |
| US6063763A (en)* | 1989-04-28 | 2000-05-16 | Schering Aktiengesellschaft | Protease-resistant thrombomodulin analogs |
| US6239101B1 (en) | 1989-07-05 | 2001-05-29 | Oklahoma Medical Research Foundation | Thrombin binding polypeptides |
| CA2022713A1 (en)* | 1989-08-11 | 1991-02-12 | Nils U. Bang | Human thrombomodulin derivatives |
| EP0489180A4 (en)* | 1990-06-27 | 1993-03-31 | Mochida Pharmaceutical Co., Ltd. | Anticoagulant polypeptides |
| KR930008093B1 (en)* | 1990-08-03 | 1993-08-25 | 아사히가세이고오교 가부시끼가이샤 | New polypeptide and its composition |
| ATE211390T1 (en)* | 1990-08-15 | 2002-01-15 | Paion Gmbh | SUPERIOR THROMBOMODULIN ANALOGS FOR PHARMACEUTICAL USE |
| CA2129370A1 (en)* | 1992-02-05 | 1993-08-19 | David Richard Light | Protease-resistant thrombomodulin analogs |
| US5863894A (en)* | 1995-06-05 | 1999-01-26 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
| US5872098A (en)* | 1995-06-05 | 1999-02-16 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
| US5945275A (en)* | 1994-10-18 | 1999-08-31 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
| US5866543A (en)* | 1995-06-05 | 1999-02-02 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
| CA2202351A1 (en)* | 1994-10-18 | 1996-04-25 | George Phillip Vlasuk | Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| US5866542A (en)* | 1994-10-18 | 1999-02-02 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
| EP1772516A1 (en)* | 1994-10-18 | 2007-04-11 | Dendreon Corporation | Pharmaceutical compositions for the treatment of thrombosis |
| JPH11299487A (en)* | 1996-04-03 | 1999-11-02 | Asahi Chem Ind Co Ltd | New gene |
| CN100563709C (en) | 2002-05-01 | 2009-12-02 | 舍林股份公司 | Novel tissue factor-targeting antibodies as anticoagulants |
| US7579000B2 (en) | 2002-05-01 | 2009-08-25 | Bayer Schering Pharma Ag | Tissue factor targeted antibodies as anticoagulants |
| JP5579385B2 (en) | 2006-10-06 | 2014-08-27 | 旭化成ファーマ株式会社 | Treatment and / or ameliorating agent for disseminated intravascular coagulation syndrome |
| ES2496596T3 (en) | 2007-03-23 | 2014-09-19 | Asahi Kasei Pharma Corporation | Method to produce soluble high purity thrombomodulin |
| US20120165244A1 (en)* | 2008-10-30 | 2012-06-28 | Hua-Lin Wu | Methods for binding lewis y antigen |
| TW201522633A (en) | 2010-04-30 | 2015-06-16 | Asahi Kasei Pharma Corp | High-purity soluble thrombomodulin and method for producing same |
| CN103179982A (en)* | 2010-08-05 | 2013-06-26 | 科学与工业研究委员会 | Protein fusion constructs with thrombolytic and anticoagulant properties |
| US9592275B2 (en) | 2011-11-15 | 2017-03-14 | Asahi Kasei Pharma Corporation | Medicament for therapeutic treatment and/or improvement of sepsis |
| MX364934B (en) | 2012-05-31 | 2019-03-28 | Univ Kinki | Agent for preventing and/or treating peripheral neuropathic pain caused by anti-cancer drug. |
| AU2019347406B9 (en) | 2018-09-28 | 2023-11-16 | Asahi Kasei Pharma Corporation | Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent |
| KR20210060574A (en) | 2018-10-22 | 2021-05-26 | 아사히 가세이 파마 가부시키가이샤 | Medications for the treatment and/or amelioration of sepsis with coagulation abnormalities |